On this page
Menkes disease
This severe disorder primarily impacts males and results from faulty copper transport, leading to copper deficiency in many tissues despite normal intake. It causes significant developmental and neurological problems.
Available at Jeen Health
Clinical tests that include this
Overview
Menkes disease is a serious genetic condition that disrupts the body's ability to properly absorb and distribute copper, a vital trace element. While copper is taken in through diet, individuals with Menkes disease cannot transport it effectively to various organs and tissues where it is needed for essential bodily functions [PMID:33679883]. This leads to a deficiency of copper in critical areas like the brain, liver, and hair, despite it accumulating in other places, such as the intestinal lining and kidneys. The condition is progressive and typically becomes apparent in infancy.
Menkes disease is considered a multisystemic disorder, meaning it affects many different parts of the body. Its impact can range from severe neurological degeneration to distinctive hair abnormalities and connective tissue problems. Due to its X-linked inheritance, the condition predominantly affects males, with an estimated prevalence of between 1 in 100,000 and 1 in 250,000 live male births.
Symptoms & clinical features
The symptoms of Menkes disease typically begin to show within the first few months of life, often after an initial period of apparently normal development. Early signs may include feeding difficulties, poor weight gain, and unusually low body temperature. As the condition progresses, developmental milestones, such as sitting or crawling, may be missed or delayed.
Neurological problems are a prominent feature of Menkes disease. Infants may develop seizures, muscle weakness (hypotonia), and significant developmental regression, losing skills they once had. A hallmark physical characteristic is 'steely hair' or 'kinky hair' (pili torti), which is sparse, coarse, and lighter in colour than expected. Other features can include sagging facial skin, a pudgy appearance, and problems with the skeletal system, such as brittle bones or unusual bone formations visible on X-rays [PMID:17109218].
Video: Genetics 101
Affected organs
Menkes disease impacts numerous organ systems due to widespread copper deficiency. The central nervous system is profoundly affected, leading to severe brain degeneration, seizures, and significant developmental impairment. Copper is crucial for the function of several enzymes involved in brain development and maintenance.
The skeletal system can also be affected, with bones becoming brittle and prone to fractures. The connective tissue throughout the body, including skin, blood vessels, and joints, relies on copper-dependent enzymes for its integrity, leading to issues like loose skin, joint laxity, and arterial damage. Hair follicles also require copper, resulting in the characteristic 'kinky' hair. Other systems, including the digestive tract and urinary system, can show functional problems due to the disrupted copper transport [PMID:17109218].
Risks & severity
Menkes disease is a severe and progressive disorder. Without treatment, the prognosis is generally poor, with most affected individuals experiencing significant neurological decline and not surviving beyond early childhood [PMID:33679883]. The severity can vary, though most cases are profound. There are milder forms, sometimes referred to as 'occipital horn syndrome', which have a later onset and a less severe course, but these are much rarer.
Complications often include frequent infections, breathing difficulties, and progressive neurological damage, leading to significant disability. Early diagnosis and intervention, particularly with copper supplementation, can sometimes improve the outcome, but the disease remains a serious life-limiting condition. The full spectrum of disease severity is still being understood as more individuals are diagnosed and followed over time.
Genetic causes
Menkes disease is caused by pathogenic variants in the ATP7A gene. This gene provides instructions for making a protein called a copper-transporting ATPase. This protein is like a pump that moves copper from one place to another within cells and across cell membranes.
Normally, the ATP7A protein is crucial for absorbing copper from the gut and transporting it to various tissues where it is needed for the function of copper-dependent enzymes. These enzymes are involved in many vital processes, including energy production, connective tissue formation, brain development, and maintaining healthy blood vessels [PMID:33679883]. When pathogenic variants occur in ATP7A, the protein either doesn't work correctly or isn't produced at all. This disruption means that copper cannot be properly distributed throughout the body, leading to copper deficiency in many tissues (like the brain) and accumulation in others (like the intestines and kidneys), causing the wide range of symptoms seen in Menkes disease.
- ATP7A ATPase copper transporting alphaThe ATP7A gene provides instructions for producing a protein vital for regulating copper levels within the body, ensuring proper cellular function and preventing toxicity.
Inheritance pattern
Menkes disease follows an X-linked recessive inheritance pattern. This means the ATP7A gene, which is responsible for the condition, is located on the X chromosome.
Males have one X chromosome and one Y chromosome, so if their single X chromosome carries a pathogenic variant in ATP7A, they will develop Menkes disease. Females have two X chromosomes; if one X chromosome carries a pathogenic variant, they are typically carriers and do not show symptoms because their other healthy X chromosome usually compensates. However, female carriers can pass the pathogenic variant to their children. Each son of a carrier mother has a 50% chance of inheriting the altered gene and developing Menkes disease, while each daughter has a 50% chance of being a carrier. In rare cases, females can be affected, for example, if they have two X chromosomes with the pathogenic variant, or due to a phenomenon called skewed X-inactivation.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
Diagnosis & testing
Diagnosing Menkes disease typically begins with a clinical suspicion based on the characteristic symptoms, such as developmental delay, seizures, and the unique 'kinky' hair. Blood tests can show abnormally low levels of copper and ceruloplasmin (a protein that carries copper in the blood) [PMID:17109218]. Urine tests may reveal increased copper excretion in some cases. X-rays can identify specific bone abnormalities.
The definitive diagnosis is confirmed through genetic testing, which looks for pathogenic variants in the ATP7A gene. This testing is available through the NHS Genomic Medicine Service (GMS). If Menkes disease is suspected, a referral to a clinical genetics service or a paediatric neurology team can initiate the diagnostic process. Genetic testing for ATP7A variants falls under the NHS National Genomic Test Directory R-codes, such as R335 Severe neurological copper metabolism disorders, which guides eligibility and availability of testing.
Management & lifestyle
While there is currently no cure for Menkes disease, management focuses on attempting to normalise copper levels and alleviate symptoms. Early intervention is crucial; treatment typically involves subcutaneous (under the skin) injections of copper-histidinate, a form of copper that can bypass the intestinal absorption defect [PMID:33679883]. This treatment aims to deliver copper directly to the tissues that are deficient.
Supportive care is also a vital part of management. This includes anti-epileptic medications to control seizures, physical and occupational therapy to help with developmental delays, and nutritional support for feeding difficulties. Regular monitoring of copper levels and assessment of neurological and developmental progress are essential. Management is best coordinated by a multidisciplinary team, including paediatricians, neurologists, geneticists, and dietitians, as part of the NHS care pathway. Genetic counselling is also recommended for families to understand the inheritance pattern and implications for future pregnancies.
UK care pathway
In the UK, individuals suspected of having Menkes disease would typically be referred to a specialist paediatric service, such as a paediatric neurologist or a clinical geneticist. These specialists can evaluate symptoms, arrange initial biochemical tests, and guide the process for genetic diagnosis within the NHS Genomic Medicine Service (GMS). Genetic testing for Menkes disease (ATP7A variants) is included in the NHS National Genomic Test Directory (e.g., under R335, severe neurological copper metabolism disorders).
Upon diagnosis, care is managed by a multidisciplinary team. Access to genetic counselling services is a key part of the pathway, offering support, information about the condition's inheritance, and discussions about implications for the wider family. Families are supported throughout their journey by specialist NHS teams.
Frequently asked questions
What is the typical life expectancy for someone with Menkes disease?
Menkes disease is a very serious condition. Without treatment, most children with the severe form do not survive beyond early childhood. With early diagnosis and treatment, some children may live longer, but it remains a life-limiting condition with significant health challenges.
Can Menkes disease be detected before birth?
Yes, if a pathogenic variant in the ATP7A gene has been identified in a family, prenatal diagnosis is possible through genetic testing of chorionic villus sampling (CVS) or amniocentesis during pregnancy. Preimplantation genetic diagnosis (PGD) is also an option for families undertaking IVF.
Are there any treatments that can cure Menkes disease?
Currently, there is no cure for Menkes disease. However, early treatment with copper-histidinate injections can sometimes improve neurological outcomes and extend life, particularly if started before symptoms become severe. Supportive care is also very important for managing symptoms.
Why does Menkes disease mostly affect boys?
Menkes disease is an X-linked recessive condition. Males have only one X chromosome, so if their single X chromosome carries the altered ATP7A gene, they will develop the condition. Females have two X chromosomes, and if one carries the altered gene, the other usually compensates, making them carriers rather than affected.
What is 'kinky hair' and why does it occur in Menkes disease?
'Kinky hair' (pili torti) is a characteristic symptom of Menkes disease where the hair is sparse, coarse, and twisted. This happens because copper is essential for enzymes involved in hair structure and pigmentation, and the copper deficiency disrupts normal hair development.
References
- Vairo FPE, Chwal BC, Perini S. A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease. Molecular genetics and metabolism. 2019. PMID: 30594472
- Ashrafi MR, Ghasemi D, Safavi M. Menkes Disease. Archives of Iranian medicine. 2021. PMID: 35014241
- Ramani PK, Parayil Sankaran B. Menkes Disease. 2026. PMID: 32809752
- Tümer Z, Møller LB. Menkes disease. European journal of human genetics : EJHG. 2010. PMID: 19888294
- Bertini I, Rosato A. Menkes disease. Cellular and molecular life sciences : CMLS. 2008. PMID: 17989919
- Kaler SG. Menkes disease. Advances in pediatrics. 1994. PMID: 7992686
- Merchant SS, Sagasti A. Precious metal economy. Cell metabolism. 2006. PMID: 16890535
- Gasch AT, Kaler SG, Kaiser-Kupfer M. Menkes disease. Ophthalmology. 1999. PMID: 10080197